PleoPharma, Inc. Closes $36 Million Series B Financing Round

Financing led by Biotech Specialist Funds and a Generalist with significant participation from Series A investors Proceeds will support the Phase 3 Program for patients with Cannabis Use Disorder PHOENIXVILLE, Pa., Oct. 21, 2025 /PRNewswire/ -- PleoPharma, Inc., a privately held company...

Read More